EraCal develops drugs to treat different diseases.
EraCal Therapeutics has 1 recorded funding round in the Tech.eu database (amounts undisclosed). Based in Zurich, Switzerland; founded 2018; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-10-01 | Seed | €0 |
| — |
| View deal → |
